---
$id: https://graph.org.ai/products/commodity/51151649
$type: Product
source: UNSPSC
code: "51151649"
title: "Mepenzolate"
class: "51151600"
classTitle: "Cholinergic blocking agents"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Mepenzolate

**UNSPSC Code**: 51151649
**Class**: [Cholinergic blocking agents](Cholinergic blocking agents.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antimuscarinic agent with the molecular formula C21H26NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ONW3LB39P7, chemically known as 3-hydroxy-1, 1-dimethylpiperidinium bromide benzilate but generally known as mepenzolate, which bears US NIH Compound Identifier 4057. European Medicines Agency schedules Mepenzolate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14513MIG. World Health Organization schedules mepenzolate in its Anatomical Therapeutic Chemical (ATC) Classification. MEPENZOLATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, MEPENZOLATE remains the US FDA Preferred Term for this commodity. Mepenzolate bears US NLM identifiers UMLS ID C0360172 and NCI Concept Code C61830. SMILES: O(C1C[N](CCC1)(C)C)C(=O)C(O)(C1CCCCC1)C1CCCCC1.

